All AbMole products are for research use only, cannot be used for human consumption.
Alvimopan is a gastroprokinetic peripheral mu-opioid receptor antagonist. As a drug, Alvimopan is given to patients undergoing bowel surgery to protect the bowel from the effects of opioid medications that are used to treat pain, blocking the undesirable GI side-effects of the opioid agonists without affecting analgesia or causing withdrawal. Alvimopan does not cross the blood-brain barrier, competitively binding to gastrointestinal tract mu-opioid receptors.
Molecular Weight | 424.53 |
Formula | C25H32N2O4 |
CAS Number | 156053-89-3 |
Solubility (25°C) | DMSO: 10 mg/mL |
Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[2] Shahnaz Sultan, et al. Alvimopan for recovery of bowel function after radical cystectomy
[3] Heather R Bream-Rouwenhorst, et al. Alvimopan for postoperative ileus
Related Opioid Receptor Products |
---|
SNC162
SNC162 is a delta-opioid receptor agonist with an IC50 of 0.94 nM. |
ML 190
ML 190 is a selective κ opioid receptor (KOR) antagonist with an IC50 of 120 nM and an EC50 of 129 nM, respectively. |
CCG258747
CCG258747 is a selective GRK2 inhibitor (IC50=18 nM) with high selectivity over GRK1, GRK5, PKA, and ROCK1 (518, 83, >5500, and >550–fold, respectively).CCG258747 also blocks the internalization of the µ-opioid receptor. |
Sunobinop
Sunobinop (S 117957) is a modulator of the opioid receptor-like orphan receptor (ORL1). |
SCH 486757
SCH 486757 is an orally effective pain peptide receptor (NOP) agonist. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.